- Home
- GRFS vs BOOT Comparison
GRFS vs BOOT Comparison
Compare GRFS & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- BOOT
- Stock Information
- Founded
- GRFS 1940
- BOOT 1978
- Country
- GRFS Spain
- BOOT United States
- Employees
- GRFS N/A
- BOOT N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- BOOT Clothing/Shoe/Accessory Stores
- Sector
- GRFS Health Care
- BOOT Consumer Discretionary
- Exchange
- GRFS Nasdaq
- BOOT Nasdaq
- Market Cap
- GRFS 6.6B
- BOOT 5.7B
- IPO Year
- GRFS 2006
- BOOT 2014
- Fundamental
- Price
- GRFS $9.57
- BOOT $190.30
- Analyst Decision
- GRFS Hold
- BOOT Strong Buy
- Analyst Count
- GRFS 1
- BOOT 13
- Target Price
- GRFS $10.30
- BOOT $189.77
- AVG Volume (30 Days)
- GRFS 522.4K
- BOOT 507.8K
- Earning Date
- GRFS 01-01-0001
- BOOT 10-29-2025
- Dividend Yield
- GRFS 1.48%
- BOOT N/A
- EPS Growth
- GRFS 132.60
- BOOT 29.02
- EPS
- GRFS 0.53
- BOOT 6.36
- Revenue
- GRFS $8,744,226,659.00
- BOOT $1,991,785,000.00
- Revenue This Year
- GRFS $5.46
- BOOT $15.95
- Revenue Next Year
- GRFS $6.69
- BOOT $13.13
- P/E Ratio
- GRFS $23.80
- BOOT $29.08
- Revenue Growth
- GRFS 9.32
- BOOT 16.70
- 52 Week Low
- GRFS $6.19
- BOOT $86.17
- 52 Week High
- GRFS $11.14
- BOOT $191.31
- Technical
- Relative Strength Index (RSI)
- GRFS 44.36
- BOOT 65.17
- Support Level
- GRFS $9.39
- BOOT $163.43
- Resistance Level
- GRFS $9.86
- BOOT $190.06
- Average True Range (ATR)
- GRFS 0.19
- BOOT 6.02
- MACD
- GRFS 0.00
- BOOT 2.50
- Stochastic Oscillator
- GRFS 33.32
- BOOT 99.49
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
About BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.